3-aminobenzamide and eptifibatide

3-aminobenzamide has been researched along with eptifibatide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kecskés, M; Losonczy, H; Nagy, A; Pótó, L; Szabó, C; Tóth, O	1

Other Studies

1 other study(ies) available for 3-aminobenzamide and eptifibatide

Article	Year
In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters. Life sciences, 2006, Jun-20, Volume: 79, Issue:4 Topics: Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Eptifibatide; Factor Xa Inhibitors; Female; Heparin; Humans; Indoles; Male; Partial Thromboplastin Time; Peptides; Platelet Aggregation Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Tirofiban; Tissue Plasminogen Activator; Tyrosine	2006

Article

Year

In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters.

Life sciences, 2006, Jun-20, Volume: 79, Issue:4

Topics: Aspirin; Blood Coagulation; Blood Platelets; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Eptifibatide; Factor Xa Inhibitors; Female; Heparin; Humans; Indoles; Male; Partial Thromboplastin Time; Peptides; Platelet Aggregation Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Tirofiban; Tissue Plasminogen Activator; Tyrosine

2006